Rohto Pharmaceutical to Test Coronavirus Drug That Uses Stem Cells

Economy Health Science Japan in Video

Rohto Pharmaceutical will start in August a clinical trial of a new drug to treat novel coronavirus patients. The medicine uses mesenchymal stem cells that can regenerate bones and blood vessels.

[© Nippon TV News 24 Japan]

drug NTV News 24 coronavirus COVID-19 pandemic